GREER R SCOTT — SEC insider filings
SEC reporting owner CIK 1211703. 12 insider filings on record with FilingPulse; latest filed 2026-09-25.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2020-09-24 to 2026-09-25. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | Director | 10 | — | — | 18 |
| Inogen Inc (INGN) | Director | 2 | — | — | 7 |
Insider filings — GREER R SCOTT
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-25 | 4 | NEKTAR THERAPEUTICS (NKTR) | Grant/award (A): 2,000 @ $0 · Grant/award (A): 4,000 (derivative) @ $0 | EDGAR |
| 2025-10-01 | 4 | NEKTAR THERAPEUTICS (NKTR) | Grant/award (A): 8,000 (derivative) @ $0 | EDGAR |
| 2023-09-21 | 4 | NEKTAR THERAPEUTICS (NKTR) | Grant/award (A): 85,000 (derivative) @ $0 | EDGAR |
| 2022-09-20 | 4 | NEKTAR THERAPEUTICS (NKTR) | Grant/award (A): 10,200 @ $0 · Grant/award (A): 20,400 (derivative) @ $0 | EDGAR |
| 2021-11-09 | 4 | NEKTAR THERAPEUTICS (NKTR) | Option exercise (M): 12,500 @ $12.80 · Option exercise (M): 12,500 (derivative) @ $0 | EDGAR |
| 2021-09-24 | 4 | NEKTAR THERAPEUTICS (NKTR) | Grant/award (A): 10,200 @ $0 · Grant/award (A): 20,400 (derivative) @ $0 | EDGAR |
| 2021-08-31 | 4 | NEKTAR THERAPEUTICS (NKTR) | Option exercise (M): 45,000 @ $12.70 · Option exercise (M): 45,000 (derivative) @ $0 | EDGAR |
| 2021-05-12 | 4 | Inogen Inc (INGN) | Grant/award (A): 2,754 @ $0 | EDGAR |
| 2021-02-04 | 4 | Inogen Inc (INGN) | Option exercise (M): 6,666 @ $46.66 · Option exercise (M): 3,334 @ $43.21 · Option exercise (M): 10,000 @ $44.19 · Option exercise (M): 6,666 (derivative) @ $0 · Option exercise (M): 3,334 (derivative) @ $0 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2021-01-05 | 4 | NEKTAR THERAPEUTICS (NKTR) | Option exercise (M): 40,000 @ $13.80 · Option exercise (M): 40,000 (derivative) @ $0 | EDGAR |
| 2020-09-25 | 4/A | NEKTAR THERAPEUTICS (NKTR) | Grant/award (A): 9,100 @ $0 · Grant/award (A): 18,200 (derivative) @ $0 | EDGAR |
| 2020-09-24 | 4 | NEKTAR THERAPEUTICS (NKTR) | Grant/award (A): 9,100 @ $0 · Grant/award (A): 18,200 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-24 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1211703 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs